31142341|t|TRPV1 mediates astrocyte activation and interleukin-1beta release induced by hypoxic ischemia (HI).
31142341|a|BACKGROUND: Hypoxic-ischemic encephalopathy (HIE) is a serious birth complication with high incidence in both advanced and developing countries. Children surviving from HIE often have severe long-term sequela including cerebral palsy, epilepsy, and cognitive disabilities. The severity of HIE in infants is tightly associated with increased IL-1beta expression and astrocyte activation which was regulated by transient receptor potential vanilloid 1 (TRPV1), a non-selective cation channel in the TRP family. METHODS: Neonatal hypoxic ischemia (HI) and oxygen-glucose deprivation (OGD) were used to simulate HIE in vivo and in vitro. Primarily cultured astrocytes were used for investigating the expression of glial fibrillary acidic protein (GFAP), IL-1beta, Janus kinase 2 (JAK2), signal transducer and activator of transcription 3 (STAT3), and activation of the nucleotide-binding, oligomerization domain (NOD)-like receptor pyrin domain-containing protein 3 (NLRP3) inflammasome by using Western blot, q-PCR, and immunofluorescence. Brain atrophy, infarct size, and neurobehavioral disorders were evaluated by Nissl staining, 2,3,5-triphenyltetrazolium chloride monohydrate (TTC) staining and neurobehavioral tests (geotaxis reflex, cliff aversion reaction, and grip test) individually. RESULTS: Astrocytes were overactivated after neonatal HI and OGD challenge. The number of activated astrocytes, the expression level of IL-1beta, brain atrophy, and shrinking infarct size were all downregulated in TRPV1 KO mice. TRPV1 deficiency in astrocytes attenuated the expression of GFAP and IL-1beta by reducing phosphorylation of JAK2 and STAT3. Meanwhile, IL-1beta release was significantly reduced in TRPV1 deficiency astrocytes by inhibiting activation of NLRP3 inflammasome. Additionally, neonatal HI-induced neurobehavioral disorders were significantly improved in the TRPV1 KO mice. CONCLUSIONS: TRPV1 promotes activation of astrocytes and release of astrocyte-derived IL-1beta mainly via JAK2-STAT3 signaling and activation of the NLRP3 inflammasome. Our findings provide mechanistic insights into TRPV1-mediated brain damage and neurobehavioral disorders caused by neonatal HI and potentially identify astrocytic TRPV1 as a novel therapeutic target for treating HIE in the subacute stages (24 h).
31142341	0	5	TRPV1	Gene	193034
31142341	40	57	interleukin-1beta	Gene	16176
31142341	77	93	hypoxic ischemia	Disease	MESH:D007511
31142341	95	97	HI	Disease	MESH:D007511
31142341	112	143	Hypoxic-ischemic encephalopathy	Disease	MESH:D020925
31142341	145	148	HIE	Disease	MESH:D020925
31142341	163	181	birth complication	Disease	MESH:D002493
31142341	269	272	HIE	Disease	MESH:D020925
31142341	319	333	cerebral palsy	Disease	MESH:D002547
31142341	335	343	epilepsy	Disease	MESH:D004827
31142341	349	371	cognitive disabilities	Disease	MESH:D003072
31142341	389	392	HIE	Disease	MESH:D020925
31142341	441	449	IL-1beta	Gene	3553
31142341	509	549	transient receptor potential vanilloid 1	Gene	193034
31142341	551	556	TRPV1	Gene	193034
31142341	618	643	Neonatal hypoxic ischemia	Disease	MESH:D007511
31142341	645	647	HI	Disease	MESH:D007511
31142341	653	659	oxygen	Chemical	MESH:D010100
31142341	660	667	glucose	Disease	MESH:D018149
31142341	708	711	HIE	Disease	MESH:D020925
31142341	810	841	glial fibrillary acidic protein	Gene	14580
31142341	843	847	GFAP	Gene	14580
31142341	850	858	IL-1beta	Gene	16176
31142341	860	874	Janus kinase 2	Gene	16452
31142341	876	880	JAK2	Gene	16452
31142341	883	933	signal transducer and activator of transcription 3	Gene	20848
31142341	935	940	STAT3	Gene	20848
31142341	1063	1068	NLRP3	Gene	216799
31142341	1137	1150	Brain atrophy	Disease	MESH:C566985
31142341	1152	1159	infarct	Disease	MESH:D007238
31142341	1170	1195	neurobehavioral disorders	Disease	MESH:D019954
31142341	1230	1277	2,3,5-triphenyltetrazolium chloride monohydrate	Chemical	-
31142341	1279	1282	TTC	Chemical	-
31142341	1445	1447	HI	Disease	MESH:D007511
31142341	1527	1535	IL-1beta	Gene	16176
31142341	1537	1550	brain atrophy	Disease	MESH:C566985
31142341	1566	1573	infarct	Disease	MESH:D007238
31142341	1605	1610	TRPV1	Gene	193034
31142341	1614	1618	mice	Species	10090
31142341	1620	1625	TRPV1	Gene	193034
31142341	1680	1684	GFAP	Gene	14580
31142341	1689	1697	IL-1beta	Gene	16176
31142341	1729	1733	JAK2	Gene	16452
31142341	1738	1743	STAT3	Gene	20848
31142341	1756	1764	IL-1beta	Gene	16176
31142341	1802	1807	TRPV1	Gene	193034
31142341	1858	1863	NLRP3	Gene	216799
31142341	1901	1903	HI	Disease	MESH:D007511
31142341	1912	1937	neurobehavioral disorders	Disease	MESH:D019954
31142341	1973	1978	TRPV1	Gene	193034
31142341	1982	1986	mice	Species	10090
31142341	2001	2006	TRPV1	Gene	193034
31142341	2074	2082	IL-1beta	Gene	16176
31142341	2094	2098	JAK2	Gene	16452
31142341	2099	2104	STAT3	Gene	20848
31142341	2137	2142	NLRP3	Gene	216799
31142341	2204	2209	TRPV1	Gene	193034
31142341	2219	2231	brain damage	Disease	MESH:D001925
31142341	2236	2261	neurobehavioral disorders	Disease	MESH:D019954
31142341	2281	2283	HI	Disease	MESH:D007511
31142341	2320	2325	TRPV1	Gene	193034
31142341	2369	2372	HIE	Disease	MESH:D020925
31142341	Association	14580	20848
31142341	Association	16176	216799
31142341	Positive_Correlation	MESH:D007511	16176
31142341	Positive_Correlation	193034	3553
31142341	Association	193034	216799
31142341	Association	MESH:D019954	193034
31142341	Association	MESH:D010100	MESH:D018149
31142341	Positive_Correlation	MESH:D020925	3553
31142341	Positive_Correlation	14580	193034
31142341	Positive_Correlation	16176	193034
31142341	Negative_Correlation	MESH:D010100	MESH:D020925
31142341	Association	14580	16452
31142341	Association	16452	193034
31142341	Association	16176	16452
31142341	Positive_Correlation	MESH:C566985	193034
31142341	Association	MESH:D007511	193034
31142341	Association	16176	20848
31142341	Association	193034	20848
31142341	Positive_Correlation	MESH:D007238	193034
31142341	Association	MESH:D020925	193034

